C13H14F3NO3
Neat
289.26
1234321-83-5; (R)-methyl 3-acetamido-4-(2, 4, 5-trifluorophenyl)butanoate; methyl (3R)-3-acetamido-4-(2, 4, 5-trifluorophenyl)butanoate; Benzenebutanoic acid, beta-(acetylamino)-2, 4, 5-trifluoro-, methyl ester, (betaR)-; MFCD20486546; Sitagliptin impurity O; U83QX7NXP8; SCHEMBL2572967; SCHEMBL30136577; DTXSID60676588; Methyl (R)-3-acetamido-4-(2, 4, 5-trifluorophenyl)butanoate; AKOS015837743; AKOS016008241; DA-18250; G79192; (R)-methyl3-acetamido-4-(2, 4, 5-trifluorophenyl)butanoate; Methyl 3-acetamido-4-(2, 4, 5-trifluorophenyl)butanoate, (R)-; Methyl (betaR)-beta-(acetylamino)-2, 4, 5-trifluorobenzenebutanoate; Benzenebutanoic acid, -(acetylamino)-2, 4, 5-trifluoro-, methyl ester, (R)-; Benzenebutanoic acid, ?-(acetylamino)-2, 4, 5-trifluoro-, methyl ester and (?R)-
methyl (3R)-3-acetamido-4-(2, 4 and 5-trifluorophenyl)butanoate
InChI=1S/C13H14F3NO3/c1-7(18)17-9(5-13(19)20-2)3-8-4-11(15)12(16)6-10(8)14/h4,6,9H,3,5H2,1-2H3,(H,17,18)/t9-/m1/s1